Robert Vries,
CEO,
HUB Organoids
Robert received his PhD in Biochemistry from the Leiden University Medical Center where he studied oncogenic cell transformation in the lab of Prof. van de Eb. He subsequently moved to Stanford University (USA) to pursue his post-doctoral career on neural stem cells. Upon his return to the Netherlands, he joined the group of Prof. Hans Clevers at the Hubrecht Institute where he was involved in the development of the breakthrough “Organoid Technology” that allows the expansion of adult stem cells and the development of “mini-organs in a dish”. Rob is currently CEO of HUB, which was founded to further develop and refine the Organoid Technology.
|
|
|
Add to Calendar ▼2023-06-20 09:00:002023-06-20 10:00:00Europe/LondonPatient-Derived Organoids at the Forefront of Human Disease Modeling and Therapeutics DevelopmentOrganoids and Spheroids Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
